Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
CNBXCNBX Pharmaceuticals Inc.
| Figure | CNBXCNBX Pharmaceuticals Inc.FY2025 · Aug |
|---|---|
| Revenue | $0.00 |
| Revenue, yoy | −100.0% |
| Net income | $313.98K |
| Net income, yoy | +54.8% |
| Net margin | — |
| Free cash flow | — |
| FCF margin | — |
| EPS, diluted | $0.00 |
Add another company.
Annual · FY2021–FY2025 · USD
From SEC EDGARSame fiscal periods, as filed